No Detail Found!

Brimonidine Efficacy on Intraocular Pressure Control Following Nd: Yag Laser Capsulotomy.

Author(s)
Muhammad Asaad Saleem PAF Hospital Masroor Karachi Pakistan,
Muhammad Manzoor Combined Military Hospital Lahore, PakistanPAF Hospital Masroor Karachi Pakistan, Pakistan
Asim Shehzad Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Muhammad Ramzan PAF Hospital Masroor Karachi Pakistan,
Saliha Hafeez Combined Military Hospital Multan, Pakistan
Khaula Atif Combined Military Hospital Peshawar Pakistan
Abstract
Objective: To determine the efficacy of 0.2% brimonidine eye drops on control of intraocular pressure following Neodymium: Yttrium-Aluminum-Garnet (Nd: YAG) laser posterior capsulotomy. Study Design: Quasi experimental study. Place and Duration of Study: Study was conducted in department of Ophthalmology, Combined Military Hospital Peshawar of six months duration from Oct 2013 to Mar 2014. Material and Methods: A total of 182 patients were included in this study. One drop of 0.2% brimonidine one hour prior to laser treatment was instilled in the eyes of patients. Cornea was anaesthetized with topical 0.5% proparacaine hydrochloride. “Ocular instruments ® Abraham Capsulotomy YAG contact lens” was used along with Q-switched Zeiss VISULAS YAG III (Nd: YAG) laser system to make a hole of 3-4mm in the posterior capsule using minimum amount of total laser energy. Data were analyzed using SPSS version 15.0. Mean and standard deviation was calculated for numeric variables like age and intraocular pressure at different occasions. Frequency and percentage was calculated for categoric variable i.e. gender. Efficacy was stratified among age and gender to see effect modifiers. Results: The mean age of participants was 63.3 ± 7.7 years. Out of 182 patients, 109 (59.9%) were male while remaining 73 patients (40.1%) were female. Brimonidine 0.2% eye drops proved effective in 162 patients (89.0%). Stratification of age and sex with regard to efficacy of 0.2% brimonidine eye drops was carried out. Conclusion: The use of 0.2% brimonidine has been proven effective to counteract the IOP increase following Nd: YAG laser capsulotomy in this study.
Publication Details
Page(s) 245-249
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 2, Year: 2018

Request the full text from PASTIC

References
SaeedMK,AmeenSS,IbrahimMT, 2009.Raised intraocular pressure; frequency after Nd: Yag laser capsulotomy,Professional Med J 16 410 -3
MinelloAAP,JuniorSS,MansonPA, 2008.Efficacy of eye hypotensive topic agents after posterior capsulotomy,Arq Bras Ophthalmolo 71 706 -10
WakamatsuTH,YamaguchiT,NegishiK., 2011.Functional visual acuity after neodymium:YAG laser capsulotomy in patients with posterior capsule opacification and good visual acuity preoperatively,J Cataract Refract Surg 37 258 -64
IwaseT,NishiY,OvesonBC,JoYJ, 2011.Hydrophobic versus doublesquare-edged hydrophilic foldable acrylic intraocular lens: effect on posterior capsule opacification,J Cataract Refract Surg 37 1060 -8
KugelbergM,WejdeG,JayaramH,ZetterströmC, 2008.Two-year follow-up of posterior capsule opacification after implantation of a hydrophilic or hydrophobic acrylicintraocular lens,Acta Ophthalmol 86 533 -6
WahabS,AhmedJ,Sharif-,-HasanK, 2011.Pars plana surgical capsulotomy for posterior capsular opacification (PCO),J Pak Med Assoc 61 14 -7
SinghalD,DesaiR,DesaiS,ShastriM, 2011.Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy,J Pharmacol Pharmacother 2 104 -6
Larranaga-OsunaG,Garza-CantuD, 2011.Intraocular pressure in patients undergoing capsulotomy Nd: YAG laser,Rev Med Inst Mex SeguroSoc 49 259 -66
CaiJP,ChengJW,WeiRL,MaXY,JiangF,ZhuH, 2008.Prophylactic use of Timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy,Int Ophthalmol 28 19 -22
WaseemM,KhanHA, 2010.Association of raised intraocular pressure and its correlation to the energy used with raised versus normalintraocular pressure following Nd: YAG laser posterior capsulotomy in pseudophakes,J Coll Physicians Surg Pak 20 524 -7
OnerV,AlakusMF,TasM,TurkyılmazK.,Fixed Combination, 2012.Timolol Versus Brimonidine for Treatment of Intraocular Pressure Elevation After Neodymium:YAG Laser Posterior Capsulotomy,J Ocul Pharmacol Ther 28 576 -80
ArtunayO,YuzbasiogluE,UnalM,RasierR, 2010.versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium-aluminum-garnet laser posterior capsulotomy,J Ocul Pharmacol Ther 26 513 -7
ChenTC, 2005.5% for prevention of intraocular pressure elevation after anterior segment laser surgery,J Cataract Refract Surg 31 1707 -12
MinJK,AnJH,Yim JH, 2014.A new technique for Nd:YAG laser posterior capsulotomy,Int J Ophthalmol 7 345 -9
KhanB,AlamM,ShahMA,BashirB,IqbalA,AlamA, 2014.Complications of Nd: YAG Laser Capsulotomy,Pak J Ophthalmol 30 133 -6
ElkingtonRA,FrankJH,GreaneyJM, 1999.,third editions 216 29 -
BhargavaR,KumarP,SharmaSK,KaurA, 2015.A randomized controlled trial of peeling and aspiration of Elschnig pearls and neodymium: yttrium-aluminum-garnet laser capsulotomy,Int J Ophthalmol 8 590 -6
GartaganisSP,MelaEK,KatsimprisJM,PetropoulosJK,KaramanosNK,KoliopoulosJX, 1999.Use of topical brimonidine to prevent intraocular pressure elevations following Nd:YAG laser posterior capsulotomy,Ophthalmic Surg Lasers 30 647 -52
YeomHY,LeeJH,HongYJ, 2006.Prophylactic Effect on IOP Elevation After Nd:YAG Laser Posterior Capsulotomy,J Ocul Pharmacol Ther 22 176 -81
0

Citations

0

Downloads

176

Views